NCC has been commissioned by the pharmaceutical company Novozymes to construct a modern campus – a center for biotechnology research and business development – north of Copenhagen, Denmark. The order is worth approximately €89.24m (SEK 865m).
“At NCC, we are very pleased to play a part in realizing Novozymes’ vision through the construction of a new and exciting innovation campus. The physical environment is crucial to provide people with opportunities to develop creatively,” says Palle Bjerre Rasmussen, Head of NCC Building in Denmark.
NCC will construct the first phase of Novozymes Innovation Campus, which will cover 40,200m² and house research facilities, including laboratories, and activities in the area of business development. The campus will be situated north of Copenhagen by the Technical University of Denmark (DTU), in Lyngby-Taarbæk Municipality.
The aim of this project is to build a modern campus with a creative work environment that blends into its surroundings. The four buildings will have between two and three stories and be connected with corridors to promote transdisciplinary collaboration. The buildings will also be distinguished by large sections of glazing to ensure optimum lighting conditions and to provide an inspiring view over the green areas. A 10,000m² parking garage will also be constructed.
NCC is the turnkey contractor with Vilhelm Lauritsen as the project architect, GHB as the landscape architect and Ramböll as the lead adviser.
Construction is expected to commence at the end of October 2016 when the detailed development plan is ready, and the project is scheduled for completion at the end of 2018. The order will be registered in the fourth quarter in the NCC Building business area.
Payment will be disbursed in accordance with degree of completion.
